Medtech has announced the first sale of its Rosa Spine robot in Europe. The first Rosa Spine robot was purchased by Amiens University Hospital in Amiens, France, a centre for the treatment of brain and spine disorders. The neurosurgery department, led by Johann Peltier, is renowned for its state-of-the-art equipment in imaging systems and robotics and its scientific work.
The hospital already owns a Rosa Brain robot, which has been helping surgeons perform cranial surgery since 2011. Amiens University Hospital was also one of the very first to use Rosa Spine in clinical trials led by Anthony Fichten and Michel Lefranc earlier this year.
Bertin Nahum, president and founder of Medtech commented: “This first sale of Rosa Spine in Europe, just a few months after receiving market approval, is extremely encouraging and a clear example of the interest generated by our technology for treating brain and spine disorders. In the USA, we remain on track for potential Food and Drug Administration clearance of Rosa Spine by the end of the year, which will allow us to build on the strong traction of Rosa Brain with US hospitals and enter the largest market for spine procedures.”
